A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as anti-infectives. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Gallimycin PFC, Erythromycin and phosphate. Its PubChem CID is 83935.
Erythromycin phosphate
| CAS No | 4501-00-2 |
|---|---|
| Molecular Formula | C37H70NO17P |
| Molecular Weight | 831.9 g/mol |
| Synonyms | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;phosphoric acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits.
The listed CAS number is 4501-00-2.
The listed molecular formula is C37H70NO17P.
The listed molecular weight is 831.9 g/mol.
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;phosphoric acid.
The source lists Gallimycin PFC, Erythromycin and phosphate.